AstraZeneca AG
AstraZeneca AG is a Originators company based in Baar (Zug) recorded by Swissmedic as the authorisation holder for 39 human medicines. That places it 39 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Synthetika.
Key facts
| Sector | Originators |
|---|---|
| City | Baar |
| Canton | Zug |
| Authorisation holder | Yes |
| Medicines | 39 |
| Founded | Not available |
| Employees | 201-1000 |
| Parent group | AstraZeneca plc |
| Activity | Not available |
| Website | astrazeneca.ch |
Medicines authorised in Switzerland
AstraZeneca AG is recorded by Swissmedic as the authorisation holder for 39 human medicines. The table shows 39 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
39 of 39 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Axulta | 65402 | B | A06AX04 | 2015-03-24 |
| Bricanyl Turbuhaler | 48943 | B | R03AC03 | 1987-12-10 |
| Brilique 90 mg | 61389 | B | B01AC24 | 2011-06-30 |
| Brilique 90 mg | 66822 | B | B01AC24 | 2018-03-08 |
| Calquence 100 mg | 68817 | A | L01EL02 | 2023-05-04 |
| Daxas 500 ug | 60484 | B | R03DX07 | 2011-11-18 |
| Fasenra 30 mg /1 ml | 66582 | B | R03DX10 | 2018-06-08 |
| Fasenra Pen 30 mg /1 ml | 67581 | B | R03DX10 | 2020-05-18 |
| Faslodex | 56778 | B | L02BA03 | 2004-03-19 |
| Forxiga 5 mg | 65176 | B | A10BK01 | 2014-08-19 |
| Imfinzi 120 mg/2.4 ml | 66548 | A | L01FF03 | 2018-06-11 |
| Imjudo 25 mg/1 | 68706 | A | L01FX20 | 2023-09-13 |
| Iressa | 56154 | A | L01EB01 | 2004-03-02 |
| Kombiglyze XR 5 mg/ 500 mg | 62598 | B | A10BD10 | 2012-12-19 |
| Lokelma 5 g | 67851 | B | V03AE10 | 2021-04-16 |
| Lynparza 100 mg | 66745 | A | L01XK01 | 2018-09-27 |
| Ondexxya 200 mg | 67759 | A | V03AB38 | 2020-12-02 |
| Onglyza 2.5 mg | 59390 | B | A10BH03 | 2010-02-05 |
| Orpathys 100 mg | 70151 | A | L01EP03 | 2026-02-13 |
| Oxis 6 Turbuhaler | 53997 | B | R03AC13 | 1997-02-18 |
| Pemzek 4 mg | 62498 | B | C09CA06 | 2012-01-06 |
| Pemzek PLUS 8/12.5 mg | 62499 | B | C09DA06 | 2012-01-06 |
| Pulmicort Respules 0 | 50758 | B | R03BA02 | 1992-05-26 |
| Pulmicort Turbuhaler 200 | 50192 | B | R03BA02 | 1990-03-26 |
| Qtern | 66040 | B | A10BD21 | 2017-06-26 |
| Saphnelo 120 mg/0.8 ml | 70278 | B | L04AG11 | 2026-05-12 |
| Saphnelo 300 mg/2 ml | 68512 | A | L04AG11 | 2022-08-31 |
| Symbicort 100/6 Turbuhaler | 55568 | B | R03AK07 | 2000-12-12 |
| Synagis 50 mg/0.5 ml | 65695 | A | J06BD01 | 2016-07-05 |
| Tagrisso 40 mg | 65872 | A | L01EB04 | 2016-07-11 |
| Tezspire | 68454 | B | R03DX11 | 2022-06-13 |
| Tezspire 110 mg/ml | 69080 | B | R03DX11 | 2023-08-23 |
| Trixeo Aerosphere 5/7.2/160 μg | 68388 | B | R03AL11 | 2021-11-24 |
| Truqap 160 mg | 69300 | A | L01EX27 | 2024-03-19 |
| Vannair 100/6 | 57327 | B | R03AK07 | 2005-07-27 |
| WAINZUA | 69332 | B | N07XX21 | 2025-02-14 |
| Xigduo XR 5 mg / 500 mg | 65377 | B | A10BD15 | 2015-07-16 |
| Zoladex LA SafeSystem | 53371 | A | L02AE03 | 1995-12-27 |
| Zoladex SafeSystem | 48159 | A | L02AE03 | 1990-06-28 |
Frequently asked questions
How many medicines does AstraZeneca AG have authorised in Switzerland?
AstraZeneca AG is recorded by Swissmedic as the authorisation holder for 39 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is AstraZeneca AG based?
The Swiss location recorded for AstraZeneca AG is Baar, Zug.
Is AstraZeneca AG a Swissmedic authorisation holder?
Yes. AstraZeneca AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.